Evidence map›Paper›PMID 28596301›Full record

ArticlePhysiological reports2017

Modeling elucidates how refractory period can provide profound nonlinear gain control to graded potential neurons.

Zhuoyi Song, Yu Zhou, Mikko Juusola

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Zhuoyi SongDepartment of Biomedical Science, University of Sheffield, Sheffield, United Kingdom zhuoyi.song@shef.ac.uk m.juusola@shef.ac.uk.
Yu ZhouSchool of Engineering University of Central Lancashire, Preston, United Kingdom.
Mikko JuusolaDepartment of Biomedical Science, University of Sheffield, Sheffield, United Kingdom zhuoyi.song@shef.ac.uk m.juusola@shef.ac.uk.
University of Sheffield · GBUniversity of Central Lancashire · GB

Funding

Biotechnology and Biological Sciences Research Council BB/D001900/1Biotechnology and Biological Sciences Research Council BB/F012071/1Biotechnology and Biological Sciences Research Council BB/H013849/1
6 · The paper itself

Abstract

Refractory period (RP) plays a central role in neural signaling. Because it limits an excitable membrane's recovery time from a previous excitation, it can restrict information transmission. Classically, RP means the recovery time from an action potential (spike), and its impact to encoding has been mostly studied in spiking neurons. However, many sensory neurons do not communicate with spikes but convey information by graded potential changes. In these systems, RP can arise as an intrinsic property of their quantal micro/nanodomain sampling events, as recently revealed for quantum bumps (single photon responses) in microvillar photoreceptors. Whilst RP is directly unobservable and hard to measure, masked by the graded macroscopic response that integrates numerous quantal events, modeling can uncover its role in encoding. Here, we investigate computationally how RP can affect encoding of graded neural responses. Simulations in a simple stochastic process model for a fly photoreceptor elucidate how RP can profoundly contribute to nonlinear gain control to achieve a large dynamic range.

Indexed as

Models, NeurologicalRefractory Period, ElectrophysiologicalAdaptation, PhysiologicalAnimalsDrosophilaPhotoreceptor Cells, InvertebrateVision, OcularDrosophilafly photoreceptorlarge dynamic rangeneural adaptationquantal samplingquantum bumpstochasticityvision

Identifiers

PMID28596301
PMCPMC5471445
OpenAlexW2612997879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.